<td class= Dadun
   (New user)
Help  | Contact  |  Castellano English  

Dadun > Depósito Académico > Facultad de Medicina > Departamento de Anatomía > DA - Medicina - Anatomía - Artículos de revista >

Rosiglitazone Rescues Memory Impairment in Alzheimer's Transgenic Mice: Mechanisms Involving a Reduced Amyloid and Tau Pathology
Authors: Escribano, L. (L.)
Simon, A.M. (Ana María)
Gimeno, E. (E.)
Cuadrado-Tejedor, M. (Mar)
Lopez-de-Maturana, R. (Raquel)
Garcia-Osta, A. (Ana)
Ricobaraza, A. (Ana)
Perez-Mediavilla, L.A. (Luis Alberto)
Rio, J. (Joaquín) del
Frechilla, D. (Diana)
Keywords: Alzheimer's disease
amyloid; tau
amyloid; tau
Issue Date: Mar-2010
Publisher version:
ISSN: 0893-133X
Citation: Neuropsychopharmacology 2010 Jun;35(7):1593-1604.
Clinical studies suggest that agonists at peroxisome proliferator-activated receptor gamma (PPARγ) may exert beneficial effects in patients with mild-to-moderate Alzheimer's disease (AD), but the mechanism for the potential therapeutic interest of this class of drugs has not yet been elucidated. Here, in mice overexpressing mutant human amyloid precursor protein, we found that chronic treatment with rosiglitazone, a high-affinity agonist at PPARγ, facilitated β-amyloid peptide (Aβ) clearance. Rosiglitazone not only reduced Aβ burden in the brain but, importantly, almost completely removed the abundant amyloid plaques observed in the hippocampus and entorhinal cortex of 13-month-old transgenic mice. In the hippocampus, neuropil threads containing phosphorylated tau, probably corresponding to dystrophic neurites, were also decreased by the drug. Rosiglitazone switched on the activated microglial phenotype, promoting its phagocytic ability, reducing the expression of proinflammatory markers and inducing factors for alternative differentiation. The decreased amyloid pathology may account for the reduction of p-tau-containing neuropil threads and for the rescue of impaired recognition and spatial memory in the transgenic mice. This study provides further insights into the mechanisms for the beneficial effect of rosiglitazone in AD patients.
Permanent link:
Appears in Collections:DA - Medicina - Anatomía - Artículos de revista
DA - Ciencias - Bioquímica y Biología molecular - Artículos de Revista
DA - CIMA - Neurociencias - Neurofarmacología y conducta - Artículos de Revista

Files in This Item:
File:  Papel Rosi-3.pdf
Size:  663,09 kB
Format:  Adobe PDF
 View / Open 

Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.